Trial site
Kliiniliste Uuringute Keskus OÜ
- 8running trials
- 14closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Psoriasis8 trials
- Psoriatic arthritis5 trials
- Atopic dermatitis (eczema)3 trials
- Rheumatoid arthritis2 trials
- Ankylosing spondylitis1 trial
- Asthma1 trial
- Cytomegalovirus infection1 trial
- Osteoporosis1 trial
- Phase
- Phase 318 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Completed14 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Lead sponsor
- Sun Pharmaceutical Industries Limited4 trials
- Alumis Inc2 trials
- Amgen Inc.2 trials
- ModernaTX, Inc.2 trials
- Takeda2 trials
- and 10 more
Running trials
Recruiting
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Active, not recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
Closed trials
Completed
Completed
Completed
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
Completed
Completed
Completed
Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis
Completed
Completed
Completed
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Terminated
Completed
Completed
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026